Incretin-Based Therapies for the Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes.

Cusi K.
Hepatology. 2019 Jun;69(6):2318-2322. doi: 10.1002/hep.30670.

Stay Connected